[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global De Novo Sequencing Market Growth (Status and Outlook) 2023-2029

March 2023 | 104 pages | ID: G0EB77BA4D90EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global De Novo Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for De Novo Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for De Novo Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for De Novo Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key De Novo Sequencing players cover 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “De Novo Sequencing Industry Forecast” looks at past sales and reviews total world De Novo Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected De Novo Sequencing sales for 2023 through 2029. With De Novo Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world De Novo Sequencing industry.

This Insight Report provides a comprehensive analysis of the global De Novo Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on De Novo Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global De Novo Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for De Novo Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global De Novo Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of De Novo Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Genome Survey
  • Gene Annotation
  • Evolution Analysis
  • Auxiliary Assembly
Segmentation by application
  • Oncology
  • Hereditary Disease Detection
  • Life Science
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • 10X Genomics Inc.
  • Abcam Plc
  • Exeter Clinical Laboratory
  • Psomagen
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • Eppendorf AG
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • CD Genomics
  • Illumina
  • qGenomics
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global De Novo Sequencing Market Size 2018-2029
  2.1.2 De Novo Sequencing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 De Novo Sequencing Segment by Type
  2.2.1 Genome Survey
  2.2.2 Gene Annotation
  2.2.3 Evolution Analysis
  2.2.4 Auxiliary Assembly
2.3 De Novo Sequencing Market Size by Type
  2.3.1 De Novo Sequencing Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global De Novo Sequencing Market Size Market Share by Type (2018-2023)
2.4 De Novo Sequencing Segment by Application
  2.4.1 Oncology
  2.4.2 Hereditary Disease Detection
  2.4.3 Life Science
2.5 De Novo Sequencing Market Size by Application
  2.5.1 De Novo Sequencing Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global De Novo Sequencing Market Size Market Share by Application (2018-2023)

3 DE NOVO SEQUENCING MARKET SIZE BY PLAYER

3.1 De Novo Sequencing Market Size Market Share by Players
  3.1.1 Global De Novo Sequencing Revenue by Players (2018-2023)
  3.1.2 Global De Novo Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global De Novo Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DE NOVO SEQUENCING BY REGIONS

4.1 De Novo Sequencing Market Size by Regions (2018-2023)
4.2 Americas De Novo Sequencing Market Size Growth (2018-2023)
4.3 APAC De Novo Sequencing Market Size Growth (2018-2023)
4.4 Europe De Novo Sequencing Market Size Growth (2018-2023)
4.5 Middle East & Africa De Novo Sequencing Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas De Novo Sequencing Market Size by Country (2018-2023)
5.2 Americas De Novo Sequencing Market Size by Type (2018-2023)
5.3 Americas De Novo Sequencing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC De Novo Sequencing Market Size by Region (2018-2023)
6.2 APAC De Novo Sequencing Market Size by Type (2018-2023)
6.3 APAC De Novo Sequencing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe De Novo Sequencing by Country (2018-2023)
7.2 Europe De Novo Sequencing Market Size by Type (2018-2023)
7.3 Europe De Novo Sequencing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa De Novo Sequencing by Region (2018-2023)
8.2 Middle East & Africa De Novo Sequencing Market Size by Type (2018-2023)
8.3 Middle East & Africa De Novo Sequencing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DE NOVO SEQUENCING MARKET FORECAST

10.1 Global De Novo Sequencing Forecast by Regions (2024-2029)
  10.1.1 Global De Novo Sequencing Forecast by Regions (2024-2029)
  10.1.2 Americas De Novo Sequencing Forecast
  10.1.3 APAC De Novo Sequencing Forecast
  10.1.4 Europe De Novo Sequencing Forecast
  10.1.5 Middle East & Africa De Novo Sequencing Forecast
10.2 Americas De Novo Sequencing Forecast by Country (2024-2029)
  10.2.1 United States De Novo Sequencing Market Forecast
  10.2.2 Canada De Novo Sequencing Market Forecast
  10.2.3 Mexico De Novo Sequencing Market Forecast
  10.2.4 Brazil De Novo Sequencing Market Forecast
10.3 APAC De Novo Sequencing Forecast by Region (2024-2029)
  10.3.1 China De Novo Sequencing Market Forecast
  10.3.2 Japan De Novo Sequencing Market Forecast
  10.3.3 Korea De Novo Sequencing Market Forecast
  10.3.4 Southeast Asia De Novo Sequencing Market Forecast
  10.3.5 India De Novo Sequencing Market Forecast
  10.3.6 Australia De Novo Sequencing Market Forecast
10.4 Europe De Novo Sequencing Forecast by Country (2024-2029)
  10.4.1 Germany De Novo Sequencing Market Forecast
  10.4.2 France De Novo Sequencing Market Forecast
  10.4.3 UK De Novo Sequencing Market Forecast
  10.4.4 Italy De Novo Sequencing Market Forecast
  10.4.5 Russia De Novo Sequencing Market Forecast
10.5 Middle East & Africa De Novo Sequencing Forecast by Region (2024-2029)
  10.5.1 Egypt De Novo Sequencing Market Forecast
  10.5.2 South Africa De Novo Sequencing Market Forecast
  10.5.3 Israel De Novo Sequencing Market Forecast
  10.5.4 Turkey De Novo Sequencing Market Forecast
  10.5.5 GCC Countries De Novo Sequencing Market Forecast
10.6 Global De Novo Sequencing Forecast by Type (2024-2029)
10.7 Global De Novo Sequencing Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 10X Genomics Inc.
  11.1.1 10X Genomics Inc. Company Information
  11.1.2 10X Genomics Inc. De Novo Sequencing Product Offered
  11.1.3 10X Genomics Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 10X Genomics Inc. Main Business Overview
  11.1.5 10X Genomics Inc. Latest Developments
11.2 Abcam Plc
  11.2.1 Abcam Plc Company Information
  11.2.2 Abcam Plc De Novo Sequencing Product Offered
  11.2.3 Abcam Plc De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Abcam Plc Main Business Overview
  11.2.5 Abcam Plc Latest Developments
11.3 Exeter Clinical Laboratory
  11.3.1 Exeter Clinical Laboratory Company Information
  11.3.2 Exeter Clinical Laboratory De Novo Sequencing Product Offered
  11.3.3 Exeter Clinical Laboratory De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Exeter Clinical Laboratory Main Business Overview
  11.3.5 Exeter Clinical Laboratory Latest Developments
11.4 Psomagen
  11.4.1 Psomagen Company Information
  11.4.2 Psomagen De Novo Sequencing Product Offered
  11.4.3 Psomagen De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Psomagen Main Business Overview
  11.4.5 Psomagen Latest Developments
11.5 BGI Genomics Co. Ltd.
  11.5.1 BGI Genomics Co. Ltd. Company Information
  11.5.2 BGI Genomics Co. Ltd. De Novo Sequencing Product Offered
  11.5.3 BGI Genomics Co. Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 BGI Genomics Co. Ltd. Main Business Overview
  11.5.5 BGI Genomics Co. Ltd. Latest Developments
11.6 Bio Rad Laboratories Inc.
  11.6.1 Bio Rad Laboratories Inc. Company Information
  11.6.2 Bio Rad Laboratories Inc. De Novo Sequencing Product Offered
  11.6.3 Bio Rad Laboratories Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Bio Rad Laboratories Inc. Main Business Overview
  11.6.5 Bio Rad Laboratories Inc. Latest Developments
11.7 Danaher Corp.
  11.7.1 Danaher Corp. Company Information
  11.7.2 Danaher Corp. De Novo Sequencing Product Offered
  11.7.3 Danaher Corp. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Danaher Corp. Main Business Overview
  11.7.5 Danaher Corp. Latest Developments
11.8 Eppendorf AG
  11.8.1 Eppendorf AG Company Information
  11.8.2 Eppendorf AG De Novo Sequencing Product Offered
  11.8.3 Eppendorf AG De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Eppendorf AG Main Business Overview
  11.8.5 Eppendorf AG Latest Developments
11.9 Eurofins Scientific SE
  11.9.1 Eurofins Scientific SE Company Information
  11.9.2 Eurofins Scientific SE De Novo Sequencing Product Offered
  11.9.3 Eurofins Scientific SE De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Eurofins Scientific SE Main Business Overview
  11.9.5 Eurofins Scientific SE Latest Developments
11.10 F. Hoffmann-La Roche Ltd.
  11.10.1 F. Hoffmann-La Roche Ltd. Company Information
  11.10.2 F. Hoffmann-La Roche Ltd. De Novo Sequencing Product Offered
  11.10.3 F. Hoffmann-La Roche Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.11 CD Genomics
  11.11.1 CD Genomics Company Information
  11.11.2 CD Genomics De Novo Sequencing Product Offered
  11.11.3 CD Genomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 CD Genomics Main Business Overview
  11.11.5 CD Genomics Latest Developments
11.12 Illumina
  11.12.1 Illumina Company Information
  11.12.2 Illumina De Novo Sequencing Product Offered
  11.12.3 Illumina De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Illumina Main Business Overview
  11.12.5 Illumina Latest Developments
11.13 qGenomics
  11.13.1 qGenomics Company Information
  11.13.2 qGenomics De Novo Sequencing Product Offered
  11.13.3 qGenomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 qGenomics Main Business Overview
  11.13.5 qGenomics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. De Novo Sequencing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Genome Survey
Table 3. Major Players of Gene Annotation
Table 4. Major Players of Evolution Analysis
Table 5. Major Players of Auxiliary Assembly
Table 6. De Novo Sequencing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global De Novo Sequencing Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global De Novo Sequencing Market Size Market Share by Type (2018-2023)
Table 9. De Novo Sequencing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global De Novo Sequencing Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global De Novo Sequencing Market Size Market Share by Application (2018-2023)
Table 12. Global De Novo Sequencing Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global De Novo Sequencing Revenue Market Share by Player (2018-2023)
Table 14. De Novo Sequencing Key Players Head office and Products Offered
Table 15. De Novo Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global De Novo Sequencing Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global De Novo Sequencing Market Size Market Share by Regions (2018-2023)
Table 20. Global De Novo Sequencing Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global De Novo Sequencing Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas De Novo Sequencing Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas De Novo Sequencing Market Size Market Share by Country (2018-2023)
Table 24. Americas De Novo Sequencing Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas De Novo Sequencing Market Size Market Share by Type (2018-2023)
Table 26. Americas De Novo Sequencing Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas De Novo Sequencing Market Size Market Share by Application (2018-2023)
Table 28. APAC De Novo Sequencing Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC De Novo Sequencing Market Size Market Share by Region (2018-2023)
Table 30. APAC De Novo Sequencing Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC De Novo Sequencing Market Size Market Share by Type (2018-2023)
Table 32. APAC De Novo Sequencing Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC De Novo Sequencing Market Size Market Share by Application (2018-2023)
Table 34. Europe De Novo Sequencing Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe De Novo Sequencing Market Size Market Share by Country (2018-2023)
Table 36. Europe De Novo Sequencing Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe De Novo Sequencing Market Size Market Share by Type (2018-2023)
Table 38. Europe De Novo Sequencing Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe De Novo Sequencing Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa De Novo Sequencing Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa De Novo Sequencing Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa De Novo Sequencing Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa De Novo Sequencing Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa De Novo Sequencing Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa De Novo Sequencing Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of De Novo Sequencing
Table 47. Key Market Challenges & Risks of De Novo Sequencing
Table 48. Key Industry Trends of De Novo Sequencing
Table 49. Global De Novo Sequencing Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global De Novo Sequencing Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global De Novo Sequencing Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global De Novo Sequencing Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. 10X Genomics Inc. Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 54. 10X Genomics Inc. De Novo Sequencing Product Offered
Table 55. 10X Genomics Inc. De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. 10X Genomics Inc. Main Business
Table 57. 10X Genomics Inc. Latest Developments
Table 58. Abcam Plc Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 59. Abcam Plc De Novo Sequencing Product Offered
Table 60. Abcam Plc Main Business
Table 61. Abcam Plc De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Abcam Plc Latest Developments
Table 63. Exeter Clinical Laboratory Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 64. Exeter Clinical Laboratory De Novo Sequencing Product Offered
Table 65. Exeter Clinical Laboratory Main Business
Table 66. Exeter Clinical Laboratory De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Exeter Clinical Laboratory Latest Developments
Table 68. Psomagen Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 69. Psomagen De Novo Sequencing Product Offered
Table 70. Psomagen Main Business
Table 71. Psomagen De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Psomagen Latest Developments
Table 73. BGI Genomics Co. Ltd. Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 74. BGI Genomics Co. Ltd. De Novo Sequencing Product Offered
Table 75. BGI Genomics Co. Ltd. Main Business
Table 76. BGI Genomics Co. Ltd. De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. BGI Genomics Co. Ltd. Latest Developments
Table 78. Bio Rad Laboratories Inc. Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 79. Bio Rad Laboratories Inc. De Novo Sequencing Product Offered
Table 80. Bio Rad Laboratories Inc. Main Business
Table 81. Bio Rad Laboratories Inc. De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Bio Rad Laboratories Inc. Latest Developments
Table 83. Danaher Corp. Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 84. Danaher Corp. De Novo Sequencing Product Offered
Table 85. Danaher Corp. Main Business
Table 86. Danaher Corp. De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Danaher Corp. Latest Developments
Table 88. Eppendorf AG Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 89. Eppendorf AG De Novo Sequencing Product Offered
Table 90. Eppendorf AG Main Business
Table 91. Eppendorf AG De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Eppendorf AG Latest Developments
Table 93. Eurofins Scientific SE Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 94. Eurofins Scientific SE De Novo Sequencing Product Offered
Table 95. Eurofins Scientific SE Main Business
Table 96. Eurofins Scientific SE De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Eurofins Scientific SE Latest Developments
Table 98. F. Hoffmann-La Roche Ltd. Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 99. F. Hoffmann-La Roche Ltd. De Novo Sequencing Product Offered
Table 100. F. Hoffmann-La Roche Ltd. Main Business
Table 101. F. Hoffmann-La Roche Ltd. De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. F. Hoffmann-La Roche Ltd. Latest Developments
Table 103. CD Genomics Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 104. CD Genomics De Novo Sequencing Product Offered
Table 105. CD Genomics De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. CD Genomics Main Business
Table 107. CD Genomics Latest Developments
Table 108. Illumina Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 109. Illumina De Novo Sequencing Product Offered
Table 110. Illumina Main Business
Table 111. Illumina De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Illumina Latest Developments
Table 113. qGenomics Details, Company Type, De Novo Sequencing Area Served and Its Competitors
Table 114. qGenomics De Novo Sequencing Product Offered
Table 115. qGenomics Main Business
Table 116. qGenomics De Novo Sequencing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. qGenomics Latest Developments

LIST OF FIGURES

Figure 1. De Novo Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global De Novo Sequencing Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. De Novo Sequencing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. De Novo Sequencing Sales Market Share by Country/Region (2022)
Figure 8. De Novo Sequencing Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global De Novo Sequencing Market Size Market Share by Type in 2022
Figure 10. De Novo Sequencing in Oncology
Figure 11. Global De Novo Sequencing Market: Oncology (2018-2023) & ($ Millions)
Figure 12. De Novo Sequencing in Hereditary Disease Detection
Figure 13. Global De Novo Sequencing Market: Hereditary Disease Detection (2018-2023) & ($ Millions)
Figure 14. De Novo Sequencing in Life Science
Figure 15. Global De Novo Sequencing Market: Life Science (2018-2023) & ($ Millions)
Figure 16. Global De Novo Sequencing Market Size Market Share by Application in 2022
Figure 17. Global De Novo Sequencing Revenue Market Share by Player in 2022
Figure 18. Global De Novo Sequencing Market Size Market Share by Regions (2018-2023)
Figure 19. Americas De Novo Sequencing Market Size 2018-2023 ($ Millions)
Figure 20. APAC De Novo Sequencing Market Size 2018-2023 ($ Millions)
Figure 21. Europe De Novo Sequencing Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa De Novo Sequencing Market Size 2018-2023 ($ Millions)
Figure 23. Americas De Novo Sequencing Value Market Share by Country in 2022
Figure 24. United States De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC De Novo Sequencing Market Size Market Share by Region in 2022
Figure 29. APAC De Novo Sequencing Market Size Market Share by Type in 2022
Figure 30. APAC De Novo Sequencing Market Size Market Share by Application in 2022
Figure 31. China De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 35. India De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe De Novo Sequencing Market Size Market Share by Country in 2022
Figure 38. Europe De Novo Sequencing Market Size Market Share by Type (2018-2023)
Figure 39. Europe De Novo Sequencing Market Size Market Share by Application (2018-2023)
Figure 40. Germany De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 41. France De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa De Novo Sequencing Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa De Novo Sequencing Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa De Novo Sequencing Market Size Market Share by Application (2018-2023)
Figure 48. Egypt De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country De Novo Sequencing Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 54. APAC De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 55. Europe De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 57. United States De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 58. Canada De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 59. Mexico De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 60. Brazil De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 61. China De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 62. Japan De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 63. Korea De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 65. India De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 66. Australia De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 67. Germany De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 68. France De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 69. UK De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 70. Italy De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 71. Russia De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 72. Spain De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 73. Egypt De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 74. South Africa De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 75. Israel De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 76. Turkey De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries De Novo Sequencing Market Size 2024-2029 ($ Millions)
Figure 78. Global De Novo Sequencing Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global De Novo Sequencing Market Size Market Share Forecast by Application (2024-2029)


More Publications